A vote taken by the sound of applause rang out during an early morning session at (AAO) 2026 annual meeting, where 2 experts discussed the pros and cons of using complement inhibitors to treat ...
The Bimatoprost Drug Pad-IOL (BIM-IOL) System, developed by SpyGlass Pharma, uses 2 drug-eluting pads attached to the lens to ...
In the pivotal BRUNELLO trial, both doses of remigromig, a Wnt pathway agonist, were noninferior to ranibizumab for diabetic ...
A session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help ...
COA's Nicolas Ferreyros discusses real-world survival data for community oncology, health system consolidation, and barriers to CAR T-cell access. OneOncology's Edward "Ted" Arrowsmith, MD, MPH, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results